3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Prostatic Neoplasms
2
Breast Neoplasms
2
Osteosarcoma
1
Metastatic Breast Cancer With Bone Involvement
1
Insulin Resistance
1
Interventions
Zoledronic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Metastatic Breast Cancer With Bone Involvement
×
Zoledronic Acid
×
Clear all
NCT01344967
2015-06-23
SuBDuE
University Health Network, Toronto
Phase 2/3
Completed
21 enrolled